Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumor Malignancy”

6,126 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,126 results

Not applicableStudy completedNCT02111889
What this trial is testing

Tumor Kinase Inhibitor Concentrations Measured by PET

Who this might be right for
Disseminated Malignant Neoplasm
Amsterdam UMC, location VUmc 8
Early research (Phase 1)Looking for participantsNCT06958679
What this trial is testing

Evaluation of SYS6005 in Patients With Advanced Malignant Tumor

Who this might be right for
B-cell MalignanciesSolid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd. 132
Early research (Phase 1)Looking for participantsNCT05176483
What this trial is testing

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+7 more
Exelixis 1,314
Early research (Phase 1)Ended earlyNCT00351325
What this trial is testing

BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies

Who this might be right for
Advanced Solid Malignancies
Bristol-Myers Squibb 45
Testing effectiveness (Phase 2)Looking for participantsNCT07446855
What this trial is testing

Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours

Who this might be right for
Solid Tumours
AstraZeneca 180
Testing effectiveness (Phase 2)Study completedNCT03665285
What this trial is testing

A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid TumorsLung CancerBreast Cancer+6 more
NextCure, Inc. 109
Testing effectiveness (Phase 2)Study completedNCT05661578
What this trial is testing

Evaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Participants With Locally Advanced, Recurrent or Metastatic Solid Tumors

Who this might be right for
PD-L1-selected Solid Tumors
Hoffmann-La Roche 64
Early research (Phase 1)Active Not RecruitingNCT05339685
What this trial is testing

BL-M02D1 in Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer or Other Solid Tumors

Who this might be right for
Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 82
Early research (Phase 1)Study completedNCT03744403
What this trial is testing

CS1001 in Subjects with Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
CStone Pharmaceuticals 24
Not applicableNot Yet RecruitingNCT07645742
What this trial is testing

Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors

Who this might be right for
Cancer (Advanced Stage)
West Virginia University 90
Early research (Phase 1)Study completedNCT00750425
What this trial is testing

Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours

Who this might be right for
Advanced Solid Tumors
AstraZeneca 46
Early research (Phase 1)Not Yet RecruitingNCT07567859
What this trial is testing

HS-10587 in Patients With Advanced Solid Tumors

Who this might be right for
MTAP Deletion
Jiangsu Hansoh Pharmaceutical Co., Ltd. 362
Testing effectiveness (Phase 2)Active Not RecruitingNCT05744427
What this trial is testing

Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 725
Early research (Phase 1)Study completedNCT02070549
What this trial is testing

Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Solid Neoplasm+1 more
National Cancer Institute (NCI) 46
Early research (Phase 1)Study completedNCT01755390
What this trial is testing

A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Sanofi 42
Early research (Phase 1)Ended earlyNCT03936959
What this trial is testing

LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company 10
Early research (Phase 1)Study completedNCT00400296
What this trial is testing

R547 in Patients With Advanced Solid Tumors.

Who this might be right for
Neoplasms
Hoffmann-La Roche 58
Early research (Phase 1)Looking for participantsNCT06265688
What this trial is testing

First In Human Study of CX-2051 in Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
CytomX Therapeutics 160
Early research (Phase 1)Study completedNCT01423903
What this trial is testing

Phase 1, Open-label Trial to Determine Safety of OPB-51602 in Subjects With Advanced Cancer

Who this might be right for
Advanced Cancer
Otsuka Pharmaceutical Development & Commercialization, Inc. 45
Early research (Phase 1)Looking for participantsNCT06332170
What this trial is testing

ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Hansoh BioMedical R&D Company 610
Load More Results